Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Apple
AAPL
|
+$3.05B |
| 2 |
Broadcom
AVGO
|
+$1.54B |
| 3 |
NVIDIA
NVDA
|
+$1.43B |
| 4 |
Microsoft
MSFT
|
+$1.3B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.66B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.21B |
| 3 |
Imperial Oil
IMO
|
+$797M |
| 4 |
Vale
VALE
|
+$561M |
| 5 |
Canadian Natural Resources
CNQ
|
+$543M |
Sector Composition
| 1 | Technology | 23.76% |
| 2 | Financials | 9.79% |
| 3 | Healthcare | 8.86% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Arbutus Biopharma
ABUS
$886M
| $486K | ﹤0.01% |
157,329
-17,376
| -10% | -$53.7K |
|
|
NVX
3927
NOVONIX
NVX
$202M
| $486K | ﹤0.01% |
+271,363
| New | +$486K |
|
3928
Lifeway Foods
LWAY
$492M
| $483K | ﹤0.01% |
37,854
+4,040
| +12% | +$51.6K |
|
3929
Seres Therapeutics
MCRB
$154M
| $483K | ﹤0.01% |
33,348
-19,859
| -37% | -$287K |
|
3930
South Plains Financial
SPFI
$656M
| $483K | ﹤0.01% |
17,878
+2,030
| +13% | +$54.8K |
|
3931
Inspire Global Hope ETF
BLES
$124M
| $482K | ﹤0.01% |
+13,214
| New | +$482K |
|
3932
AN2 Therapeutics
ANTX
$33.6M
| $482K | ﹤0.01% |
224,185
+195,815
| +690% | +$421K |
|
3933
8x8 Inc
EGHT
$285M
| $481K | ﹤0.01% |
216,456
-130,416
| -38% | -$290K |
|
3934
Calvert US Select Equity ETF
CVSE
$14M
| $480K | ﹤0.01% |
7,481
-3,287
| -31% | -$211K |
|
|
GTHX
3935
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $480K | ﹤0.01% |
210,623
-237,338
| -53% | -$541K |
|
3936
Sangamo Therapeutics
SGMO
$160M
| $478K | ﹤0.01% |
1,333,454
+700,826
| +111% | +$251K |
|
3937
Blue Foundry Bancorp
BLFY
$200M
| $477K | ﹤0.01% |
52,559
+21,085
| +67% | +$191K |
|
3938
SPDR S&P 500 ESG ETF
EFIV
$1.16B
| $476K | ﹤0.01% |
8,965
+155
| +2% | +$8.23K |
|
3939
Neurogene
NGNE
$265M
| $475K | ﹤0.01% |
13,055
-61,032
| -82% | -$2.22M |
|
3940
Entrada Therapeutics
TRDA
$199M
| $475K | ﹤0.01% |
33,302
+15,979
| +92% | +$228K |
|
3941
Target Hospitality
TH
$876M
| $472K | ﹤0.01% |
54,197
-27,850
| -34% | -$243K |
|
|
THRD
3942
DELISTED
Third Harmonic Bio
THRD
| $472K | ﹤0.01% |
36,312
-31,571
| -47% | -$410K |
|
|
TBCH
3943
Turtle Beach Corporation Common Stock
TBCH
$297M
| $470K | ﹤0.01% |
32,809
-47,121
| -59% | -$676K |
|
|
GAU
3944
Galiano Gold
GAU
$644M
| $469K | ﹤0.01% |
272,866
+217,763
| +395% | +$375K |
|
3945
Hooker Furnishings Corp
HOFT
$117M
| $468K | ﹤0.01% |
32,351
-3,284
| -9% | -$47.6K |
|
3946
Latham Group
SWIM
$911M
| $468K | ﹤0.01% |
154,592
+34,663
| +29% | +$105K |
|
3947
RBB Bancorp
RBB
$333M
| $468K | ﹤0.01% |
24,860
+14,168
| +133% | +$267K |
|
3948
Kyverna Therapeutics
KYTX
$174M
| $467K | ﹤0.01% |
+62,290
| New | +$467K |
|
|
CUTR
3949
DELISTED
Cutera, Inc.
CUTR
| $467K | ﹤0.01% |
309,231
+208,896
| +208% | +$315K |
|
3950
First Trust Small Cap Value AlphaDEX Fund
FYT
$140M
| $467K | ﹤0.01% |
9,021
| – | – |
|